Market Currents
Jazz Pharmaceuticals (JAZZ): Q2 EPS of $1.09 beats by $0.04. Revenue of $130M beats by $5M....
-
Tuesday, August 7, 2012, 4:19 PM ETJazz Pharmaceuticals (JAZZ): Q2 EPS of $1.09 beats by $0.04. Revenue of $130M beats by $5M. Shares +2.4% AH.
Other date
Latest Earnings Articles
